Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-02-12 Sale |
2024-02-12 5:23 pm |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
3,683 | $1.007 | $3,709 | 307,161 (Direct) |
View |
| 2024-02-12 Sale |
2024-02-12 5:23 pm |
X4 Pharmaceuticals Inc | XFOR | Taveras Arthur Chief Scientific Officer |
787 | $1.0072 | $793 | 248,536 (Direct) |
View |
| 2024-02-12 Sale |
2024-02-12 5:05 pm |
X4 Pharmaceuticals Inc | XFOR | Ragan Paula President and CEO |
21,695 | $1.0091 | $21,892 | 814,746 (Direct) |
View |
| 2024-02-12 Sale |
2024-02-12 5:03 pm |
X4 Pharmaceuticals Inc | XFOR | Mostafa Adam S. Chief Financial Officer |
27,721 | $1.0091 | $27,973 | 52,500 (Direct) |
View |
| 2023-11-01 Sale |
2023-11-03 5:26 pm |
X4 Pharmaceuticals Inc | XFOR | Ragan Paula President and CEO |
239,437 | $0.75833 | $181,573 | 836,441 (Direct) |
View |
| 2023-11-01 Sale |
2023-11-03 4:42 pm |
X4 Pharmaceuticals Inc | XFOR | Mostafa Adam S. Chief Financial Officer |
230,645 | $0.73 | $168,371 | 80,221 (Direct) |
View |
| 2023-11-01 Sale |
2023-11-03 4:40 pm |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
67,695 | $0.73 | $49,417 | 310,844 (Direct) |
View |
| 2023-11-01 Sale |
2023-11-03 4:39 pm |
X4 Pharmaceuticals Inc | XFOR | Baldry Mark Chief Commercial Officer |
10,257 | $0.73 | $7,488 | 24,690 (Direct) |
View |
| 2023-11-01 Sale |
2023-11-03 4:39 pm |
X4 Pharmaceuticals Inc | XFOR | Taveras Arthur Chief Scientific Officer |
67,695 | $0.73 | $49,417 | 249,323 (Direct) |
View |
| 2023-09-08 Sale |
2023-09-12 4:04 pm |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
2,642 | $1.249 | $3,300 | 147,894 (Direct) |
View |
| 2023-08-18 Purchase |
2023-08-22 4:09 pm |
X4 Pharmaceuticals Inc | XFOR | WYZGA MICHAEL S Director |
25,000 | $1.195 | $29,875 | 76,667 (Direct) |
View |
| 2023-08-10 Sale |
2023-08-11 7:26 pm |
X4 Pharmaceuticals Inc | XFOR | Stewart Murray Interim Chief Medical Officer |
130,056 | $1.06 | $137,859 | 146,504 (Direct) |
View |
| 2023-06-30 Sale |
2023-07-05 4:05 pm |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
464 | $1.89 | $877 | 150,536 (Direct) |
View |
| 2023-06-30 Sale |
2023-07-05 4:04 pm |
X4 Pharmaceuticals Inc | XFOR | Mostafa Adam S. Chief Financial Officer |
2,641 | $1.89 | $4,991 | 80,221 (Direct) |
View |
| 2023-06-23 Sale |
2023-06-26 4:15 pm |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
857 | $1.93 | $1,654 | 151,000 (Direct) |
View |
| 2023-06-23 Sale |
2023-06-26 4:13 pm |
X4 Pharmaceuticals Inc | XFOR | Mostafa Adam S. Chief Financial Officer |
5,417 | $1.93 | $10,455 | 82,862 (Direct) |
View |
| 2023-06-23 Sale |
2023-06-26 4:11 pm |
X4 Pharmaceuticals Inc | XFOR | Ragan Paula President and CEO |
6,724 | $1.92 | $12,910 | 543,797 (Direct) |
View |
| 2023-06-15 Sale |
2023-06-16 4:24 pm |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
857 | $2.23 | $1,911 | 151,857 (Direct) |
View |
| 2023-06-15 Sale |
2023-06-16 4:17 pm |
X4 Pharmaceuticals Inc | XFOR | Mostafa Adam S. Chief Financial Officer |
5,417 | $2.22 | $12,026 | 88,279 (Direct) |
View |
| 2023-06-15 Sale |
2023-06-16 4:15 pm |
X4 Pharmaceuticals Inc | XFOR | Ragan Paula President and CEO |
6,724 | $2.23 | $14,995 | 550,521 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-13 Option Award |
2024-02-16 5:11 pm |
N/A 2034-02-13 |
X4 Pharmaceuticals Inc | XFOR | Arbet-Engels Christophe Chief Medical Officer |
475,831 | $0 | 475,831 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-16 5:10 pm |
N/A 2034-02-13 |
X4 Pharmaceuticals Inc | XFOR | Mostafa Adam S. Chief Financial Officer |
523,414 | $0 | 523,414 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-16 5:09 pm |
N/A 2034-02-13 |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
428,248 | $0 | 428,248 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-16 5:09 pm |
N/A 2034-02-13 |
X4 Pharmaceuticals Inc | XFOR | Ragan Paula President and CEO |
1,189,578 | $0 | 1,189,578 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-16 5:09 pm |
N/A 2034-02-13 |
X4 Pharmaceuticals Inc | XFOR | Baldry Mark Chief Commercial Officer |
523,414 | $0 | 523,414 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-16 5:08 pm |
N/A 2034-02-13 |
X4 Pharmaceuticals Inc | XFOR | Taveras Arthur Chief Scientific Officer |
428,248 | $0 | 428,248 (Direct) |
View |
| 2023-10-31 Option Award |
2023-11-02 5:04 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | Mostafa Adam S. Chief Financial Officer |
230,645 | $0 | 310,866 (Direct) |
View |
| 2023-10-31 Option Award |
2023-11-02 5:00 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | Baldry Mark Chief Commercial Officer |
34,947 | $0 | 34,947 (Direct) |
View |
| 2023-10-31 Option Award |
2023-11-02 4:59 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | Taveras Arthur Chief Scientific Officer |
230,645 | $0 | 317,018 (Direct) |
View |
| 2023-10-31 Option Award |
2023-11-02 4:58 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | Ragan Paula President and CEO |
532,081 | $0 | 1,075,878 (Direct) |
View |
| 2023-10-31 Option Award |
2023-11-02 4:55 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
230,645 | $0 | 378,539 (Direct) |
View |
| 2023-10-16 Option Award |
2023-10-18 4:02 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | Woods Keith Director |
90,000 | $0 | 90,000 (Direct) |
View |
| 2023-08-31 Option Award |
2023-09-05 4:15 pm |
N/A 2033-08-30 |
X4 Pharmaceuticals Inc | XFOR | Arbet-Engels Christophe Chief Medical Officer |
1,250,000 | $1.28 | 1,250,000 (Direct) |
View |
| 2023-08-09 Option Award |
2023-08-11 7:26 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | Stewart Murray Interim Chief Medical Officer |
269,893 | $0 | 146,504 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-14 5:10 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | Aliski William Director |
45,000 | $0 | 51,667 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-14 5:05 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | Bridger Gary Director |
45,000 | $0 | 51,667 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-14 5:03 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | MCGIRR DAVID W J Director |
45,000 | $0 | 51,667 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-14 4:59 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | WYZGA MICHAEL S Director |
45,000 | $0 | 51,667 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-14 4:57 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | de Craecker Francoise Director |
45,000 | $0 | 51,667 (Direct) |
View |